Global Tuberculosis Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Tuberculosis, also known as TB is a chronic infectious disease that affects the lungs and may also affect the other parts of the body. It is caused by a bacterial germ named Mycobacterium Tuberculosis. The major symptoms of TB include fever, loss of weight, night sweats, mucus containing blood while coughing or sneezing. Tuberculosis is a communicable disease which normally spreads in the air while coughing, sneezing, spitting, or speaking. The diagnosis of TB is performed through a microscopic examination, or chest x-rays. The growing prevalence of tuberculosis across the globe is the major factor driving the growth of the TB drugs market globally. The major focus of developing tuberculosis drugs is to shorten the duration of the treatment, and overcome certain challenges such as drug-resistant TB and drug-susceptible TB. The global tuberculosis drugs market is accounted approximate USD 1203.8 million in 2020 and it is expected to reach approximate USD 1960.9 million by 2030 with a CAGR of 5% during forecast period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020202
Market Dynamics and Factors:
Rising occurrence of multi-drug resistant (MDR) tuberculosis and drug susceptible (DS) tuberculosis cases, and growing R&D towards drug development are the major factors driving the growth of the tuberculosis drugs market globally. For instance, according to W.H.O in 2016, there were around 10.4 million cases of tuberculosis across the globe. Tuberculosis is the second most infectious killer disease claiming adult lives after HIV. The rising levels of air pollution along with increasing consumption of cigarettes are other major factors attributing to the prevalence of tuberculosis. This in turn is contributing towards the growth of the tuberculosis drugs market. Additionally, collaborations among international organisations such as WHO, UNICEF, UNCTAD, and TB alliance are focussing on developing shorter treatment regimens to fight drug resistance. This is expected to drive the growth of the tuberculosis drugs market. Apart from this, governments in high-risk nations are taking initiatives to counter the menace of TB and hence accelerating the market growth of TB drugs in the region. For instance, the Chinese government achieved a financial aid of 33 million USD through a partnership with Bill & Melinda Gates foundation to enhance detection and treatment of tuberculosis. However, high pricing of drugs and increasing drug recall are major factors restraining the growth of the tuberculosis drugs market. For instance, in 2018, Sandoz recalled a batch of its wrongly packed TB drugs in India. In 2016, a drug named Onecure manufactured by Novartis was recalled by Philippines Food & Drug Administration because of insufficient amount of rifampicin in the drug.
Market Segmentation:
Global Tuberculosis Drugs Market – By Disease Type
Active Tuberculosis
Latent Tuberculosis
Global Tuberculosis Drugs Market – By End-User
Hospital Pharmacy
Retail Pharmacy
Others
Global Tuberculosis Drugs Market – By Drug Class
First-Line Anti-Tb Drugs
Second-Line Anti-Tb Drugs
Combination Drugs
Global Tuberculosis Drugs Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020202
Geographic Analysis:
North America is expected to dominate the global tuberculosis drugs market in terms of market share during the forecast period. Presence of a large number of drug manufacturers, growing geriatric population, and increasing cases of chronic tuberculosis are major factors driving the TB drugs market in the region. Europe is estimated to witness a significant growth in the global tuberculosis drugs market during the forecast period owing to a sizeable geriatric population. For instance, according to the U.K government, in 2017 around 57,9776 people in the U.K were above 90 years of age. The Asia Pacific region is estimated to be the fastest growing market for tuberculosis drugs during the forecast period. According to the W.H.O, around 45% of the population in South East Asia suffers from tuberculosis. The growing number of tuberculosis cases in South East Asian countries is driving the market in the APAC region. ROW market is expected to witness substantial tuberculosis drugs market growth during the forecast period.
Competitive Scenario:
The key players operating in the global tuberculosis drugs market are –
Novartis AG, Pfizer Inc., Lupin, Johnson & Johnson, Otsuka Pharmaceuticals Co., Macleod Pharmaceuticals Ltd., Hoffman-La Roche Ltd., Sigma Pharmaceutical Pvt Ltd., Aventis Pharmaceuticals Ltd., Bayer Health Care, Cipla Limited, Merck & Co., Sanofi, Zydus Cadilla.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020202
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Tuberculosis Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Tuberculosis Drugs Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Tuberculosis Drugs Market most.
The data analysis present in the Global Tuberculosis Drugs Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Tuberculosis Drugs Market business.
The 2021 Annual Global Tuberculosis Drugs Market offers:
100+ charts exploring and analysing the Global Tuberculosis Drugs Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Tuberculosis Drugs Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020202
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/